Gilead Sciences, Inc., 10% Owner at Arcus Biosciences, Inc. (RCUS), bought 1,010,000 shares at $19.26 ($19.5M) on 2023-06-28, disclosed to the SEC on 2023-06-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| XLO | BUY | 2024-12-19 | $3.7M | — | Filing → |
| XLO | BUY | 2024-04-03 | $369K | — | Filing → |
| KYTX | BUY | 2024-02-13 | $20.0M | — | Filing → |